Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
Clinical trial NCT05050084 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05050084
- Sponsor
- NRG Oncology
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-06
- Primary completion
- 2026-11-11
- Enrollment
- 2050
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.